195 related articles for article (PubMed ID: 17123337)
1. Radio-guided surgery for non-131I-avid thyroid cancer.
Rubello D; Pelizzo MR; Casara D; Piotto A; Toniato A; Fig L; Gross M
Thyroid; 2006 Nov; 16(11):1105-11. PubMed ID: 17123337
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
[TBL] [Abstract][Full Text] [Related]
3. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
4. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
5. (99m)Tc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure, and preliminary clinical results.
Rubello D; Piotto A; Pagetta C; Pelizzo MR; Casara D
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1201-5. PubMed ID: 12192566
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.
Sriprapaporn J; Toopmongkol C; Satayaban B; Chantamoon N
Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557
[TBL] [Abstract][Full Text] [Related]
7. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
[TBL] [Abstract][Full Text] [Related]
8. Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature.
Negele T; Meisetschläger G; Brückner T; Scheidhauer K; Schwaiger M; Vogelsang H
Langenbecks Arch Surg; 2006 Jun; 391(3):178-86. PubMed ID: 16491404
[TBL] [Abstract][Full Text] [Related]
9. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
10. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
Travagli JP; Cailleux AF; Ricard M; Baudin E; Caillou B; Parmentier C; Schlumberger M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2675-80. PubMed ID: 9709930
[TBL] [Abstract][Full Text] [Related]
11. Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer.
Salvatori M; Rufini V; Reale F; Samanes Gajate AM; Maussier ML; Revelli L; Troncone L; Ardito G
World J Surg; 2003 Jul; 27(7):770-5. PubMed ID: 14509503
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
13. [Outcome in cervical recurrences of papillary or follicular thyroid cancer].
Mirallié E; Hamy A; Floch I; Sagan C; Paineau J; Murat A; Le Néel JC; Visset J
Ann Chir; 1999; 53(7):577-82. PubMed ID: 10520496
[TBL] [Abstract][Full Text] [Related]
14. Use of
Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D
Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
[TBL] [Abstract][Full Text] [Related]
15. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
16. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
Mirallié E; Guillan T; Bridji B; Resche I; Rousseau C; Ansquer C; Bodet-Milin C; Curtet C; Carnaille B; Murat A; Charbonnel B; Kraeber-Bodéré F
Surgery; 2007 Dec; 142(6):952-8; discussion 952-8. PubMed ID: 18063081
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.
Fujie S; Okumura Y; Sato S; Akaki S; Katsui K; Himei K; Takemoto M; Kanazawa S
Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563
[TBL] [Abstract][Full Text] [Related]
19. Radioguided thyroidectomy for follicular tumors: Multicentric experience.
Parmeggiani D; Gambardella C; Patrone R; Polistena A; De Falco M; Ruggiero R; Cirocchi R; Sanguinetti A; Cuccurullo V; Accardo M; Avenia N; Docimo G; Tolone S; Bassi V; Docimo L; Conzo G
Int J Surg; 2017 May; 41 Suppl 1():S75-S81. PubMed ID: 28506419
[TBL] [Abstract][Full Text] [Related]
20. Radioguided surgery with combined use of gamma probe and hand-held gamma camera for treatment of papillary thyroid cancer locoregional recurrences: a preliminary study.
Bellotti C; Castagnola G; Tierno SM; Centanini F; Sparagna A; Vetrone I; Mezzetti G
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3362-6. PubMed ID: 24379068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
